Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person UniProt:Q05513 PRKCZ
| Class:Id | ReferenceGeneProduct:58219 |
|---|---|
| _chainChangeLog | chain:1-592 added on Sat February 7 2015 |
| _displayName | UniProt:Q05513 PRKCZ |
| _timestamp | 2025-02-21 19:49:21 |
| chain | chain:1-592 |
| checksum | 88CCD0577E6A596C |
| comment | FUNCTION Calcium- and diacylglycerol-independent serine/threonine-protein kinase that functions in phosphatidylinositol 3-kinase (PI3K) pathway and mitogen-activated protein (MAP) kinase cascade, and is involved in NF-kappa-B activation, mitogenic signaling, cell proliferation, cell polarity, inflammatory response and maintenance of long-term potentiation (LTP). Upon lipopolysaccharide (LPS) treatment in macrophages, or following mitogenic stimuli, functions downstream of PI3K to activate MAP2K1/MEK1-MAPK1/ERK2 signaling cascade independently of RAF1 activation. Required for insulin-dependent activation of AKT3, but may function as an adapter rather than a direct activator. Upon insulin treatment may act as a downstream effector of PI3K and contribute to the activation of translocation of the glucose transporter SLC2A4/GLUT4 and subsequent glucose transport in adipocytes. In EGF-induced cells, binds and activates MAP2K5/MEK5-MAPK7/ERK5 independently of its kinase activity and can activate JUN promoter through MEF2C. Through binding with SQSTM1/p62, functions in interleukin-1 signaling and activation of NF-kappa-B with the specific adapters RIPK1 and TRAF6. Participates in TNF-dependent transactivation of NF-kappa-B by phosphorylating and activating IKBKB kinase, which in turn leads to the degradation of NF-kappa-B inhibitors. In migrating astrocytes, forms a cytoplasmic complex with PARD6A and is recruited by CDC42 to function in the establishment of cell polarity along with the microtubule motor and dynein. In association with FEZ1, stimulates neuronal differentiation in PC12 cells. In the inflammatory response, is required for the T-helper 2 (Th2) differentiation process, including interleukin production, efficient activation of JAK1 and the subsequent phosphorylation and nuclear translocation of STAT6. May be involved in development of allergic airway inflammation (asthma), a process dependent on Th2 immune response. In the NF-kappa-B-mediated inflammatory response, can relieve SETD6-dependent repression of NF-kappa-B target genes by phosphorylating the RELA subunit at 'Ser-311'. Phosphorylates VAMP2 in vitro (PubMed:17313651). Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking (PubMed:36040231).FUNCTION Involved in late synaptic long term potention phase in CA1 hippocampal cells and long term memory maintenance.CATALYTIC ACTIVITY L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+)CATALYTIC ACTIVITY L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+)ACTIVITY REGULATION Atypical PKCs (PRKCI and PRKCZ) exhibit an elevated basal enzymatic activity (that may be due to the interaction with SMG1 or SQSTM1) and are not regulated by diacylglycerol, phosphatidylserine, phorbol esters or calcium ions. Two specific sites, Thr-410 (activation loop of the kinase domain) and Thr-560 (turn motif), need to be phosphorylated for its full activation. Phosphatidylinositol 3,4,5-trisphosphate might be a physiological activator (By similarity). Isoform 2: Constitutively active (By similarity).SUBUNIT Forms a ternary complex with SQSTM1 and KCNAB2. Forms another ternary complex with SQSTM1 and GABRR3. Forms a complex with SQSTM1 and MAP2K5 (By similarity). Interacts with PARD6A, PARD6B, PARD6G and SQSTM1. Part of a complex with PARD3, PARD6A or PARD6B or PARD6G and CDC42 or RAC1. Interacts with ADAP1/CENTA1. Forms a ternary complex composed of SQSTM1 and PAWR. Interacts directly with SQSTM1 (Probable). Interacts with IKBKB. Interacts (via the protein kinase domain) with WWC1. Forms a tripartite complex with WWC1 and DDR1, but predominantly in the absence of collagen. Component of the Par polarity complex, composed of at least phosphorylated PRKCZ, PARD3 and TIAM1. Interacts with PDPK1 (via N-terminal region). Interacts with WDFY2 (via WD repeats 1-3) (PubMed:16792529). Interacts with VAMP2 (PubMed:17313651). Forms a complex with WDFY2 and VAMP2 (PubMed:17313651). Interacts with APPL1 (PubMed:26583432). Interacts with WWC1, WWC2 and WWC3 (PubMed:24682284).INTERACTION In the retina, localizes in the terminals of the rod bipolar cells (By similarity). Associates with endosomes (PubMed:9566925). Presence of KRIT1, CDH5 and RAP1B is required for its localization to the cell junction (PubMed:7597083). Colocalizes with VAMP2 and WDFY2 in intracellular vesicles (PubMed:17313651). Transiently translocates to the membrane of CA1 hippocampal cells in response to the induction of long term potentiation (By similarity).SUBCELLULAR LOCATION Expressed in brain, and to a lesser extent in lung, kidney and testis.DOMAIN The PB1 domain mediate mutually exclusive interactions with SQSTM1 and PARD6B.DOMAIN The C1 domain does not bind the diacylglycerol (DAG).PTM CDH5 is required for its phosphorylation at Thr-410. Phosphorylated by protein kinase PDPK1; phosphorylation is inhibited by the apoptotic C-terminal cleavage product of PKN2. Phosphorylation at Thr-410 by PI3K activates the kinase.MISCELLANEOUS Produced by alternative promoter usage.SIMILARITY Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.CAUTION Reported to phosphorylate STK11 leading to nuclear export of STK11, subsequent inhibition of PI3K/Akt signaling, and increased apoptosis in vein endothelial cells treated with the oxidant peroxynitrite (PubMed:18321849). However this paper was withdrawn by the authors due to concerns of image duplication in the figures. Its role in protein phosphorylation has been confirmed in other studies (PubMed:15084291, PubMed:15324659).SEQUENCE CAUTION Truncated N-terminus. |
| description | recommendedName: Protein kinase C zeta type ecNumber evidence="18 20 30"2.7.11.13 alternativeName: nPKC-zeta |
| geneName | PRKCZ PKC2 |
| identifier | Q05513 |
| isSequenceChanged | FALSE |
| keyword | Alternative promoter usage Alternative splicing ATP-binding Cell junction Cytoplasm Endosome Inflammatory response Kinase Membrane Metal-binding Nucleotide-binding Phosphoprotein Proteomics identification Reference proteome Serine/threonine-protein kinase Transferase Zinc Zinc-finger |
| modified | [InstanceEdit:9836292] Weiser, Joel, 2023-05-25 [InstanceEdit:9852000] Weiser, Joel, 2023-11-03 [InstanceEdit:9862192] Weiser, Joel, 2024-02-26 [InstanceEdit:9926675] Weiser, Joel, 2024-11-03 [InstanceEdit:9939033] Weiser, Joel, 2025-02-21 |
| name | PRKCZ |
| referenceDatabase | [ReferenceDatabase:2] UniProt |
| referenceGene | [ReferenceDNASequence:8998955] ENSEMBL:ENSG00000067606 PRKCZ [Homo sapiens] |
| secondaryIdentifier | KPCZ_HUMAN A8K4N0 A8MU64 B7Z2J7 E9PCW2 Q15207 Q5SYT5 Q969S4 |
| sequenceLength | 592 |
| species | [Species:48887] Homo sapiens |
| (isoformParent) | [ReferenceIsoform:8974337] UniProt:Q05513-1 PRKCZ [Homo sapiens] [ReferenceIsoform:8974338] UniProt:Q05513-2 PRKCZ [Homo sapiens] [ReferenceIsoform:8974339] UniProt:Q05513-3 PRKCZ [Homo sapiens] |
| (referenceEntity) | [EntityWithAccessionedSequence:58218] PRKCZ [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:437181] p-T410-PRKCZ [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:2134483] PRKCZ [cell junction] [Homo sapiens] [EntityWithAccessionedSequence:5218698] p-T410,T563-PRKCZ [cytosol] [Homo sapiens] [EntityWithAccessionedSequence:9632824] pS, p-T410-PRKCZ [cytosol] [Homo sapiens] |
| (referenceSequence) | [ModifiedResidue:437180] O-phospho-L-threonine at 410 [ModifiedResidue:5218732] O-phospho-L-threonine at 560 [ModifiedResidue:9632826] O-phospho-L-serine at unknown position |
| [Change default viewing format] | |
No pathways have been reviewed or authored by UniProt:Q05513 PRKCZ (58219)
